{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T09:35:02Z","timestamp":1784194502068,"version":"3.55.0"},"reference-count":24,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2016,11,21]],"date-time":"2016-11-21T00:00:00Z","timestamp":1479686400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100014588","name":"Sanofi Pasteur","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100014588","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2017,1]]},"DOI":"10.1016\/j.vaccine.2016.11.062","type":"journal-article","created":{"date-parts":[[2016,11,27]],"date-time":"2016-11-27T23:30:33Z","timestamp":1480289433000},"page":"299-304","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"title":["Post-licensure, phase IV, safety study of a live attenuated Japanese encephalitis recombinant vaccine in children in Thailand"],"prefix":"10.1016","volume":"35","author":[{"given":"Tawee","family":"Chotpitayasunondh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pornpimol","family":"Pruekprasert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thanyawee","family":"Puthanakit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chitsanu","family":"Pancharoen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Auchara","family":"Tangsathapornpong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peninnah","family":"Oberdorfer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pope","family":"Kosalaraksa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olarn","family":"Prommalikit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suwimon","family":"Tangkittithaworn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phirangkul","family":"Kerdpanich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chonnamet","family":"Techasaensiri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanna","family":"Korejwo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sunate","family":"Chuenkitmongkol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guy","family":"Houillon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2016.11.062_b0005","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1007\/s13365-014-0285-z","article-title":"Flaviviruses, an expanding threat in public health: focus on dengue, West Nile, and Japanese encephalitis virus","volume":"20","author":"Daep","year":"2014","journal-title":"J Neurovirol"},{"key":"10.1016\/j.vaccine.2016.11.062_b0010","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1136\/jnnp.68.4.405","article-title":"Japanese encephalitis","volume":"68","author":"Solomon","year":"2000","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.vaccine.2016.11.062_b0015","series-title":"Japanese encephalitis and West Nile viruses","first-page":"12","article-title":"Japanese encephalitis: ecology and epidemiology","author":"Endy","year":"2002"},{"key":"10.1016\/j.vaccine.2016.11.062_b0020","first-page":"435","article-title":"Epidemiology of Japanese encephalitis: past, present, and future prospects","volume":"11","author":"Wang","year":"2015","journal-title":"Ther Clin Risk Manage"},{"key":"10.1016\/j.vaccine.2016.11.062_b0025","first-page":"69","article-title":"Japanese encephalitis vaccines: WHO position paper \u2013 February 2015","volume":"90","author":"World Health Organization","year":"2015","journal-title":"Wkly Epidemiol Rec"},{"key":"10.1016\/j.vaccine.2016.11.062_b0030","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1586\/erv.10.139","article-title":"IMOJEV(\u00ae): a Yellow fever virus-based novel Japanese encephalitis vaccine","volume":"9","author":"Appaiahgari","year":"2010","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.vaccine.2016.11.062_b0035","doi-asserted-by":"crossref","first-page":"3095","DOI":"10.1128\/JVI.73.4.3095-3101.1999","article-title":"Yellow fever\/Japanese encephalitis chimeric viruses: construction and biological properties","volume":"73","author":"Chambers","year":"1999","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2016.11.062_b0040","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1097\/INF.0b013e3181f68e9c","article-title":"Safety and immunogenicity of a single administration of live-attenuated Japanese encephalitis vaccine in previously primed 2- to 5-year-olds and naive 12- to 24-month-olds: multicenter randomized controlled trial","volume":"29","author":"Chokephaibulkit","year":"2010","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2016.11.062_b0045","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1097\/INF.0000000000000276","article-title":"Primary immunization of infants and toddlers in Thailand with Japanese encephalitis chimeric virus vaccine in comparison with SA14-14-2: a randomized study of immunogenicity and safety","volume":"33","author":"Feroldi","year":"2014","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2016.11.062_b0050","doi-asserted-by":"crossref","first-page":"929","DOI":"10.4161\/hv.20071","article-title":"Single-dose, live-attenuated Japanese encephalitis vaccine in children aged 12\u201318 months: randomized, controlled phase 3 immunogenicity and safety trial","volume":"8","author":"Feroldi","year":"2012","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.vaccine.2016.11.062_b0055","doi-asserted-by":"crossref","first-page":"5363","DOI":"10.1016\/j.vaccine.2014.02.085","article-title":"Concomitant administration of live attenuated Japanese encephalitis chimeric virus vaccine (JE-CV) and measles, mumps, rubella (MMR) vaccine: randomized study in toddlers in Taiwan","volume":"32","author":"Huang","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.11.062_b0060","doi-asserted-by":"crossref","first-page":"7993","DOI":"10.1016\/j.vaccine.2010.09.035","article-title":"Immunogenicity, safety and tolerability in adults of a new single-dose, live-attenuated vaccine against Japanese encephalitis: randomised controlled phase 3 trials","volume":"28","author":"Torresi","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.11.062_b0065","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1586\/14760584.2016.1123097","article-title":"Safety and immunogenicity of a live attenuated Japanese encephalitis chimeric virus vaccine (IMOJEV(R)) in children","volume":"15","author":"Chokephaibulkit","year":"2016","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.vaccine.2016.11.062_b0070","unstructured":"Pasteur S. IMOJEV Australian Product Information; 2015. <https:\/\/www.ebs.tga.gov.au\/ebs\/picmi\/picmirepository.nsf\/pdf?OpenAgent=&id=CP-2012-PI-02773-1&d=2016042116114622483>."},{"key":"10.1016\/j.vaccine.2016.11.062_b0075","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/j.vaccine.2009.09.098","article-title":"Preclinical and clinical development of YFV 17D-based chimeric vaccines against dengue, West Nile and Japanese encephalitis viruses","volume":"28","author":"Guy","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.11.062_b0080","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1002\/(SICI)1097-0258(19980430)17:8<857::AID-SIM777>3.0.CO;2-E","article-title":"Two-sided confidence intervals for the single proportion: comparison of seven methods","volume":"17","author":"Newcombe","year":"1998","journal-title":"Stat Med"},{"key":"10.1016\/j.vaccine.2016.11.062_b0085","doi-asserted-by":"crossref","first-page":"5875","DOI":"10.1016\/j.vaccine.2014.08.001","article-title":"Post-marketing surveillance of live-attenuated Japanese encephalitis vaccine safety in China","volume":"32","author":"Wang","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.11.062_b0090","doi-asserted-by":"crossref","first-page":"8669","DOI":"10.1016\/j.vaccine.2011.08.117","article-title":"Safety profile of the Vero cell-derived Japanese encephalitis virus (JEV) vaccine IXIARO((R))","volume":"29","author":"Schuller","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.11.062_b0095","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1086\/422454","article-title":"Fever after immunization: current concepts and improved future scientific understanding","volume":"39","author":"Kohl","year":"2004","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2016.11.062_b0100","doi-asserted-by":"crossref","first-page":"384","DOI":"10.3345\/kjp.2014.57.9.384","article-title":"Febrile seizures","volume":"57","author":"Chung","year":"2014","journal-title":"Korean J Pediatr"},{"key":"10.1016\/j.vaccine.2016.11.062_b0105","doi-asserted-by":"crossref","first-page":"335","DOI":"10.5698\/1535-7511-15.6.335","article-title":"Vaccination triggers, rather than causes, seizures","volume":"15","author":"Scheffer","year":"2015","journal-title":"Epilepsy Curr"},{"key":"10.1016\/j.vaccine.2016.11.062_b0110","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1097\/WCO.0b013e3280555160","article-title":"Vaccination, seizures and \u2019vaccine damage\u2019","volume":"20","author":"Brown","year":"2007","journal-title":"Curr Opin Neurol"},{"key":"10.1016\/j.vaccine.2016.11.062_b0115","unstructured":"World Health Organization. Neurological disorders: public health challenges; 2006. <http:\/\/www.who.int\/mental_health\/neurology\/neurological_disorders_report_web.pdf>."},{"key":"10.1016\/j.vaccine.2016.11.062_b0120","first-page":"45","article-title":"Incidence and prevalence","volume":"vol. I","author":"Banerjee","year":"2008"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X16311331?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X16311331?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:24:30Z","timestamp":1759400670000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X16311331"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1]]},"references-count":24,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017,1]]}},"alternative-id":["S0264410X16311331"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2016.11.062","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2017,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Post-licensure, phase IV, safety study of a live attenuated Japanese encephalitis recombinant vaccine in children in Thailand","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2016.11.062","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}